|
|
Blood, 15 February 2007, Vol. 109, No. 4, pp. 1524-1532.
Prepublished online as a Blood First Edition Paper on October 5, 2006; DOI 10.1182/blood-2006-08-041970.
 Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro
Yoshito Takeda1,
Alexander R. Kazarov1,
Catherine E. Butterfield2,
Benjamin D. Hopkins3,
Laura E. Benjamin3,
Arja Kaipainen2, and
Martin E. Hemler1
1 Dana-Farber Cancer Institute, Boston, MA;
2 Vascular Biology Program, Children's Hospital, Boston, MA;
3 Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
Tetraspanin protein CD151 is abundant on endothelial cells. To determine whether CD151 affects angiogenesis, Cd151-null mice were prepared. Cd151-null mice showed no vascular defects during normal development or during neonatal oxygen-induced retinopathy. However, Cd151-null mice showed impaired pathologic angiogenesis in other in vivo assays (Matrigel plug, corneal micropocket, tumor implantation) and in the ex vivo aortic ring assay. Cd151-null mouse lung endothelial cells (MLECs) showed normal adhesion and proliferation, but marked alterations in vitro, in assays relevant to angiogenesis (migration, spreading, invasion, Matrigel contraction, tube and cable formation, spheroid sprouting). Consistent with these functional impairments, and with the close, preferential association of CD151 with laminin-binding integrins, Cd151-null MLECs also showed selective signaling defects, particularly on laminin substrate. Adhesion-dependent activation of PKB/c-Akt, e-NOS, Rac, and Cdc42 was diminished, but Raf, ERK, p38 MAP kinase, FAK, and Src were unaltered. In Cd151-null MLECs, connections were disrupted between laminin-binding integrins and at least 5 other proteins. In conclusion, CD151 modulates molecular organization of laminin-binding integrins, thereby supporting secondary (ie, after cell adhesion) functions of endothelial cells, which are needed for some types of pathologic angiogenesis in vivo. Selective effects of CD151 on pathologic angiogenesis make it a potentially useful target for anticancer therapy.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
X. H. Yang, A. L. Richardson, M. I. Torres-Arzayus, P. Zhou, C. Sharma, A. R. Kazarov, M. M. Andzelm, J. L. Strominger, M. Brown, and M. E. Hemler
CD151 Accelerates Breast Cancer by Regulating {alpha}6 Integrin Function, Signaling, and Molecular Organization
Cancer Res.,
May 1, 2008;
68(9):
3204 - 3213.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Lekishvili, E. Fromm, M. Mujoomdar, and F. Berditchevski
The tumour-associated antigen L6 (L6-Ag) is recruited to the tetraspanin-enriched microdomains: implication for tumour cell motility
J. Cell Sci.,
March 1, 2008;
121(5):
685 - 694.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Hu, A. Dandapat, and J. L Mehta
Angiotensin II Induces Capillary Formation From Endothelial Cells Via the LOX-1 Dependent Redox-Sensitive Pathway
Hypertension,
November 1, 2007;
50(5):
952 - 957.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Liu, B. He, W. M. Liu, D. Zhou, J. V. Cox, and X. A. Zhang
Tetraspanin CD151 Promotes Cell Migration by Regulating Integrin Trafficking
J. Biol. Chem.,
October 26, 2007;
282(43):
31631 - 31642.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. D. Merdek, X. Yang, C. A. Taglienti, L. M. Shaw, and A. M. Mercurio
Intrinsic Signaling Functions of the beta4 Integrin Intracellular Domain
J. Biol. Chem.,
October 12, 2007;
282(41):
30322 - 30330.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
